Table 1 Patient characteristics and tumor entities
Age [years] | ||||
|---|---|---|---|---|
n | % | Median | Range | |
All patients | 151 | 100 | 64.8 | 18.5- 84.4 |
Male | 84 | 55.6 | ||
Female | 67 | 44.4 | ||
Malignancy | ||||
Group I: lung cancer | 37 | 24.5 | 62.8 | 43.9- 83.5 |
Adeno | 15 | 9.9 | ||
Small cell | 10 | 6.6 | ||
Squamous | 10 | 6.6 | ||
Other non small cell | 2 | 1.3 | ||
Group II: breast cancer | 10 | 6.6 | 55.9 | 34.9- 71.3 |
Ductal | 9 | 90 | ||
Lobular | 1 | 10 | ||
Group III: gastrointestinal | 16 | 10.6 | 67.5 | 42.3- 84.4 |
Stomach cancer | 3 | 2.0 | ||
Colorectal cancer | 7 | 4.6 | ||
Other | 6 | 4.0 | ||
Group IV: hematological | 62 | 41.1 | 64.2 | 18.5- 83.2 |
Acute myeloid leukemia | 7 | 4.6 | ||
Chronic myelogenous leukemia | 2 | 1.3 | ||
Hodgkin’s lymphoma | 5 | 3.3 | ||
Non-Hodgkin’s lymphoma | 13 | 8.6 | ||
Other lymphoma | 7 | 4.6 | ||
Multiple myeloma | 13 | 8.6 | ||
Idiopathic thrombocytopenia | 5 | 3.3 | ||
Myelodysplastic syndrome | 10 | 6.6 | ||
Group V: urogenital cancers | 8 | 5.3 | 64.4 | 38.4- 81.7 |
Ovarian cancer | 2 | 1.3 | ||
Testicular cancer | 2 | 1.3 | ||
Prostate cancer | 1 | 0.7 | ||
Urinary tract cancer | 3 | 2.0 | ||
Group VI: CUP | 5 | 3.3 | 64.7 | 41.2- 80.6 |
Group VII: other solid tumors | 13 | 8.6 | 64.1 | 30.7- 73.5 |